Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

A Vasopressin-Induced Change in Prostaglandin Receptor Subtype Expression Explains the Differential Effect of PGE2 on AQP2 Expression

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Dose of Bicarbonate to Maintain Plasma pH During Maximal Ergometer Rowing and Consequence for Plasma Volume

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Editorial: Advances in Rowing Physiology

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  3. Neuropeptides and the Nodes of Ranvier in Cranial Headaches

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Peak Fat Oxidation Rate Is Closely Associated With Plasma Free Fatty Acid Concentrations in Women; Similar to Men

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Aquaporin 2 regulation: implications for water balance and polycystic kidney diseases

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Aquaporin-2 membrane targeting: still a conundrum

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  • Peter M T Deen
  • Michelle Boone
  • Horst Schweer
  • Emma T B Olesen
  • Claudia Carmone
  • Jack F M Wetzels
  • Robert A Fenton
  • Marleen L A Kortenoeven
Vis graf over relationer

Arginine vasopressin (AVP) stimulates the concentration of renal urine by increasing the principal cell expression of aquaporin-2 (AQP2) water channels. Prostaglandin E2 (PGE2) and prostaglandin2α (PGF2α) increase the water absorption of the principal cell without AVP, but PGE2 decreases it in the presence of AVP. The underlying mechanism of this paradoxical response was investigated here. Mouse cortical collecting duct (mkpCCDc14) cells mimic principal cells as they endogenously express AQP2 in response to AVP. PGE2 increased AQP2 abundance without desmopressin (dDAVP), while in the presence of dDAVP, PGE2, and PGF2α reduced AQP2 abundance. dDAVP increased the cellular PGD2 and PGE2 release and decreased the PGF2α release. MpkCCD cells expressed mRNAs for the receptors of PGE2 (EP1/EP4), PGF2 (FP), and TxB2 (TP). Incubation with dDAVP increased the expression of EP1 and FP but decreased the expression of EP4. In the absence of dDAVP, incubation of mpkCCD cells with an EP4, but not EP1/3, agonist increased AQP2 abundance, and the PGE2-induced increase in AQP2 was blocked with an EP4 antagonist. Moreover, in the presence of dDAVP, an EP1/3, but not EP4, agonist decreased the AQP2 abundance, and the addition of EP1 antagonists prevented the PGE2-mediated downregulation of AQP2. Our study shows that in mpkCCDc14 cells, reduced EP4 receptor and increased EP1/FP receptor expression by dDAVP explains the differential effects of PGE2 and PGF2α on AQP2 abundance with or without dDAVP. As the V2R and EP4 receptor, but not the EP1 and FP receptor, can couple to Gs and stimulate the cyclic adenosine monophosphate (cAMP) pathway, our data support a view that cells can desensitize themselves for receptors activating the same pathway and sensitize themselves for receptors of alternative pathways.

TidsskriftFrontiers in Physiology
Sider (fra-til)787598
StatusUdgivet - 2022

Bibliografisk note

Copyright © 2022 Deen, Boone, Schweer, Olesen, Carmone, Wetzels, Fenton and Kortenoeven.

ID: 73846169